Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 2/2024

07-12-2023 | ASO Research Letter

National Cancer Database Reports Ongoing Disruptions in Cancer Diagnoses in 2021

Authors: Lauren M. Janczewski, MD, MS, Amanda E. Browner, MS, Joseph Cotler, PhD, Bryan Palis, MA, Ryan McCabe, PhD, Daniel J. Boffa, MD, MBA, Heidi Nelson, MD

Published in: Annals of Surgical Oncology | Issue 2/2024

Login to get access

Excerpt

Year-after-year, the National Cancer Database (NCDB) has been a reliable source of cancer data, allowing researchers to consistently generate high quality cancer reports.1 However, these historically stable data models were disrupted throughout the first year of the Covid-19 pandemic with approximately 200,000 fewer newly identified cases in the NCDB in the year 2020.2 It was anticipated that these cancer cases may be captured in 2021, potentially at advanced stage disease. Our objective was to evaluate cancer case volumes, stage, and patient characteristics within the 2021 NCDB dataset before including this cohort in future research and data modeling. …
Appendix
Available only for authorised users
Literature
1.
Mallin K, Browner A, Palis B, et al. Incident cases captured in the national cancer database compared with those in US population based central cancer registries in 2012–2014. Ann Surg Oncol. 2019;26(6):1604–12.CrossRefPubMed
2.
Lum SS, Browner AE, Palis B, et al. Disruption of national cancer database data models in the first year of the COVID-19 pandemic. JAMA Surg. 2023;158(6):643–50.CrossRefPubMed
3.
Blumenthal D, Fowler EJ, Abrams M, Collins SR. Covid-19: implications for the health care system. N Engl J Med. 2020;383(15):1483–8.CrossRefPubMed
4.
Patt D, Gordan L, Diaz M, et al. Impact of COVID-19 on cancer care: How the pandemic is delaying cancer diagnosis and treatment for American seniors. JCO Clin Cancer Inform. 2020;4:1059–71.CrossRefPubMed
5.
Janczewski LM, Cotler J, Merkow RP, et al. Alterations in cancer treatment during the first year of the COVID-19 pandemic in the US. JAMA Netw Open. 2023;6(10):e2340148.CrossRefPubMedPubMedCentral
6.
Joung RH, Mullett TW, Kurtzman SH, et al. Evaluation of a national quality improvement collaborative for improving cancer screening. JAMA Netw Open. 2022;5(11):e2242354.CrossRefPubMedPubMedCentral
Metadata
Title
National Cancer Database Reports Ongoing Disruptions in Cancer Diagnoses in 2021
Authors
Lauren M. Janczewski, MD, MS
Amanda E. Browner, MS
Joseph Cotler, PhD
Bryan Palis, MA
Ryan McCabe, PhD
Daniel J. Boffa, MD, MBA
Heidi Nelson, MD
Publication date
07-12-2023
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 2/2024
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-023-14748-x

Other articles of this Issue 2/2024

Annals of Surgical Oncology 2/2024 Go to the issue

Endocrine Tumors

Defining Optimal Management of Non-metastatic Adrenocortical Carcinoma

Hepatobiliary Tumors

Laparoscopically Limited Anatomic Liver Resections: A Single-Center Analysis for Oncologic Outcomes of the Conceptual Procedure

ASO Author Reflections

ASO Author Reflections: Is Preservation of Bronchial Arteries During Esophageal Cancer Surgery Oncologically Acceptable and Does it Improve the Incidence of Postoperative Pneumonia?

Hepatobiliary Tumors

Prognostic Value of Serum α‐Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis

ASO Visual Abstract

ASO Visual Abstract: The Need of Centralization for Small Intestinal Neuroendocrine Tumor Surgery—A Cohort Study from the GTE-Endocan-RENATEN Network, the CentralChirSINET Study

ASO Author Reflections

ASO Author Reflections: Changes in Breast Cancer Management with Advances in Tumor Biology Over Time